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In this thesis, we report the use of DNA diluents to reduce surface fouling in 
peptide-containing, thiol-gold self-assembled monolayers. Two antimicrobial peptides 
previously developed as therapeutics for Methicillin-resistant Staphylococcus aureus 
(MRSA) USA300 LAC, P1 and P2, were selected as the peptide probes. Both systems 
were first tested and verified to form stable monolayers on gold electrode surfaces. Their 
responses in the presence of two complex biological samples, 50 % simulated nasal 
mucus and undiluted human serum were recorded. A large reduction in the redox signal 
from the methylene blue label on the peptide probes was observed, indicating severe 
surface fouling. To minimize surface fouling, two thiolated DNA diluents, tetra-thymine 
(T4) and tetra-adenine (A4), were separately incorporated into the P1 and P2 systems, 
and their responses upon exposure to the two matrices were analyzed. All four systems 
with a DNA diluent, P1/T4, P1/A4, P2/T4, and P2/A4, showed significantly lower signal 
reduction, verifying the antifouling capabilities of the two DNA diluents. Although this 
study’s immediate focus was not on the detection of USA300 LAC, the results are 
invaluable. It has laid the foundation for future advances in the design and fabrication of 
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USE OF THIOLATED TETRA-THYMINE AND TETRA-ADENINE AS 
ANTIFOULING DILUENTS IN ELECTROCHEMICAL PEPTIDE-BASED SENSORS 
1. Introduction 
1.1. Biosensors 
At present, biosensors represent a diverse range of commercially available testing 
devices, from point-of-care medical tests for disease diagnosis to sensors for 
identification of toxicological contamination in the food industry and environmental 
samples [1–3]. Biosensors are cost-effective, rapid, and convenient for on-site detection. 
A biosensor is primarily composed of two elements, a bioreceptor or biological 
recognition element, coupled to a transducer that produces a measurable response. The 
main advantage of biosensors is in the high sensitivity and selectivity of biological 
interactions that can be utilized to produce recognition elements. Ideally, these specific 
interactions would limit the interference from other substances with the interaction of the 
sensor with the target analyte [4]. Historically, biosensor-based diagnostic devices have 
played a significant role in the detection of disease biomarkers. The first commercially 
available biosensor was for the detection of glucose based on an oxidase enzyme 
electrode, which was sold under the name “Model 23 A YSI analyzer” by Yellow Springs 
Instrument Co., Inc. in 1975 [5].  
A biorecognition element can be any compound that binds to the analyte under 
investigation, such as antibodies, enzymes, proteins, DNA, RNA, and aptamers. It may 
naturally produce an electrical, thermal, or optical signal, or it may be modified to do so. 




Biosensors are often categorized by the combination of both the “bio” and “sensor” 
elements. To date, a wide range of transducers has been developed, including 
electrochemical (e.g., voltammetry, potentiometry, amperometry, electrochemical 
impedance spectroscopy (EIS)), optical (e.g., surface plasmon resonance (SPR) 
spectroscopy, surface-enhanced Raman spectroscopy (SERS), fluorescence), 
calorimetric, and mass-based (e.g., piezoelectric, magnetoelastic) [5]. 
The vast majority of transducers produce an optical or electrochemical response [4–
7]. Optical sensors are commonly used for the analysis of drugs, pesticides, pathogens, 
heavy metals, and other potential toxins in foodstuffs, environmental samples, and 
biological samples [8]. Many optical biosensors exhibit visible signal changes for 
convenient use, and some are detection assays that utilize low-cost, benchtop 
instrumentation. Electrochemical biosensors are equally cost-effective, time-efficient, 
user-friendly, and most can achieve highly sensitive measurements of ultra-trace analytes 
[7]. While optical sensors are versatile and have many applications, this thesis’s focus is 
on electrochemical sensors. Electrochemical transduction systems are generally 
characterized by their robustness, ease of use, and low cost. Some common electrode 
materials used in electrochemical biosensors include glassy carbon, carbon paste, 
graphite/graphene/nanotubes, gold, various metal nanoparticles, and a variety of 
composite electrodes made of a combination of these materials [4]. The choice of 
electrode material to be used in the assay is dependent on the specific target analyte and 




1.2. Electrochemical peptide- and aptamer-based biosensors  
The most common biorecognition elements in use today are nucleic acid aptamers 
and proteins, which include antibodies and enzymes. Aptamers are DNA or RNA 
molecules that can form a variety of secondary structures. They are designed to bind a 
target analyte selectively and specifically, and they are easy to synthesize and modify 
[9,10]. Proteins such as antibodies are naturally occurring molecules that bind to known 
targets with high affinity, i.e., biotin-avidin. Smaller peptide segments have proven to be 
a versatile tool for the development of folding and dynamics-based biosensors [11]. 
Peptides can still bind to target analytes with high affinity but are easier to synthesize and 
thus more cost-effective. In general, they are easier to modify than larger proteins and 
antibodies. Antimicrobial and cell-penetrating peptides can interact with cell surface 
domains, acting as peptide ligands for several receptors, such as bacterial cells, antigenic 
peptide sequences, antibodies [11–13]. The peptide backbone contains charged carboxyl 
and amine groups responsible for their hydrophilicity, which has been shown to decrease 
nonspecific protein adsorption onto surfaces because of the common hydrophobic 
interactions [14].   
Since the development of the enzyme-based glucose sensor, in which glucose oxidase 
was entrapped between two membranes, a wide variety of immobilization methods has 
been developed [10,11,14]. Biological receptors, such as enzymes, aptamers, and 
peptides, can be immobilized on the transducer surface by different methods. In 
electrochemical biosensors, bulk electrode materials can be modified with the bioreceptor 
mixed into the electrode materials, such as carbon paste or screen-printed carbon 




Bioreceptors may be incorporated into a polymeric matrix, such as polyacrylonitrile, 
polyurethane, poly(vinyl) alcohol membranes, sol-gels, or redox hydrogels. In addition, 
they can be immobilized via multi-step procedures such as covalent bonding to an 
activated electrode surface through functional groups, including glutaraldehyde, 
carbodiimide, avidin-biotin silanization, etc. [18]. Bioreceptors can also be entrapped in 
self-assembled monolayers or bilayer lipid membranes. Depending on the sensor design 
and application, these receptors may be immobilized alone or with a variety of other 
molecules [4,14]. 
Some DNA-based electrochemical biosensors’ signaling mechanism relies on the 
intrinsic redox properties of the target molecules or the change in the electrochemical 
signal upon DNA hybridization or target binding [19,20]. This type of sensors can 
function without the addition of a label; one example is the use of the oxidation signal 
from guanine for target detection [19]. In 1960 Palecek was the first to use the direct 
oxidation of guanine on a hanging mercury drop electrode to detect target DNA [21]. 
More recently, many peptides and aptamer-based electrochemical biosensors utilize the 
conformational switch design. For example, Cao et al. developed an EIS-based sensor 
using this design strategy [22]. In this design, the confirmation of the poly-T probes on 
the electrode changed from linear to a hairpin upon the binding of Hg(II), increasing the 
surface crowding. However, this sensor suffered from non-specific adsorption of matrix 
species on the electrode surface, thus increasing the false-positive signals [22]. 
Synthetic peptides are becoming more common biorecognition elements [14,23]. 
However, linear peptides tend to adopt diverse confirmations to stabilize their structure 




target analytes using specific sequences with high affinity and selectivity, however, still 
requires a signal mechanism. The conversion of target binding by the transducer into a 
processable electronic signal usually requires a redox label [23,24].  A peptide or 
aptamer-based self-assembled monolayer (SAM) is often co-adsorbed with diluent 
molecules of varied lengths that are designed to minimalize the interactions between the 
charged redox centers and the electrode surface. A hydrocarbon linker is often introduced 
between a thiol group and the peptide probe to confer flexibility and to allow less 
restricted interactions with the target analyte [14].  
The use of redox-labeled peptides is highly advantageous since it enables the analysis 
of interactions between the probe and target over a wide range of molecular affinities. 
They could also be used in enzymatic assays and immunoassays. To date, the most 
commonly used redox labels in E-PB and E-DNA sensors are methylene blue (MB), and 
ferrocene (Fc) [18]. For many of these sensors, the peptide’s ability to form a compact 
SAM is vital for efficient electron transfer, which is dependent on the length of the 
peptide, primary structure, secondary structure, and the aromatic side chains [6,25,26]. 
Short peptides are very flexible and rapidly interconvert between different conformations; 
they form loosely packed, nonhomogeneous SAMs that can have up to 15% vacant gold 
sites [25]. 
Electrochemical peptide-based biosensors have been used to detect viruses directly 
[24,27,28] as well as indirectly via antibodies produced by the immune response [27,29]. 
Peptide biorecognition elements have been developed using a myriad of techniques, 
including peptide SELEX, computational predictions, and evolutionary phage display. 




peptides with the potential to bind to a variety of biologically relevant targets. Hwang et 
al. [28] developed several short linear peptides to detect recombinant noroviral capsid 
proteins. P-domain in noroviral capsid protein is exposed on the viral surface; it is 
involved in norovirus-host cell-binding, which makes it a good target for the recognition 
of norovirus. Hwang et al. [30] later used one of these peptides as an electrochemical 
EIS- and QCM-based sensor by adding a terminal cysteine to the peptide for surface 
attachment and a 4-glycine linker for flexibility. The peptide with the sequence 
QHIMHLPHINTLGGGGSC was immobilized on the surface of the electrode for 1 hour, 
followed by backfilling in a cysteine solution for 2 hours. EIS and QCM were used to 
interrogate the sensor. The limit of detection with EIS was determined to be 99.8 nM for 
recombinant noroviral capsid proteins and 7.8 copies/mL for human norovirus. The 
sensor was able to detect its targets in 1% (v/v) fetal bovine serum. 
In recent years, owing to the ongoing outbreak of SARS-CoV-2, attention has been 
focused on the rapid and accurate detection of dangerous pathogens [31]. Biosensors that 
employ DNA and RNA biomarkers are becoming more common for diagnosis of 
infectious diseases [32]. Conventional methods of pathogen detection often rely on 
enzyme-linked immunosorbent assay (ELISA) and/or polymerase chain reaction (PCR). 
Even though these methods are highly sensitive and selective, they are time-consuming, 
labor-intensive, and may require expensive equipment [27]. Furthermore, sample pre-
treatment can be time-consuming and thus limits the applicability of these assays and 
sensors within the laboratory. A priority in biosensing research is the development of 
sensors capable of real-time analyses without complicated sample preparation, namely 




To address this concern, many researchers have focused on the development of 
sensors that are suitable for real world applications. Electrochemical biosensors have 
been integrated into microfluidic systems for use as multiplexed and miniaturized 
sensors. Li et al. [33] developed a microfluidic electrochemical array device for disease 
diagnosis that required nano to microliter of samples. This amperometric sensor was  a 
sandwich immunoassay, with the capture antibody immobilized in a SAM and alkaline 
phosphatase as the amplification label. They obtained a limited of detection (LOD) 
of 5 pg/mL in serum samples. However, its performance was not ideal when employed in 
complex matrices, presumably due to issues related to surface fouling.  
1.3. Surface fouling and antifouling strategies 
One major issue in the practical application of biosensors as medical diagnostic 
devices is issues with surface fouling in complex biological matrices. Many Biosensors 
suffer from biofouling once placed in biological fluids such as serum, plasma, blood, 
saliva, respiratory mucus, urine, and cell lysate [34,35]. When exposed to a biological 
sample, protein adsorption and cell adhesion onto the sensor surface could have various 
negative effects, such as the increase in background signals, reduction in sensitivity and 
signal-to-noise (S/N) ratios. This type of surface fouling is primarily due to the adhesion 
of proteins and other small molecule contaminants through hydrophobic and electrostatic 
attraction, and superficial nucleation [36,37]. Antifouling coatings facilitate the binding 
of water molecules, which increases surface hydrophilicity and hinders the interactions 
between the proteins and the surface [36]. Human serum albumin is the most abundant 




extracellular matrix proteins in serum, such as fibronectin, vitronectin, collagen, and 
laminin, can also non-specifically adsorb on the biosensor surface [38].  
To address the issues with surface fouling, a wide variety of antifouling coatings have 
been investigated in recent years. Some coatings enable easy removal of the adsorbed 
species (i.e., reversible adsorption), while other approaches hinder the initial adsorption 
process and interactions. One of the initial methods developed to prevent surface fouling 
via nonspecific protein adsorption and cell adhesion is the use of polymer films of 
poly(ethylene glycol) (PEG). This method is advantageous because of its low toxicity and 





Figure 1.1: Structures of polymeric films on a gold surface:  (a) linear mPEG monothiol and (b) 






1.3.1 Coatings and polymers to reduce surface fouling 
Despite being a commonly employed antifouling coating, PEG has some drawbacks; 
it is prone to oxidation damage which reduces its utility in long shelf-life devices. Linear 
PEG exhibits strong interactions with water, so direct adsorption of PEG to a surface is 
challenging, even though some groups reported using electrostatic or hydrophobic 
techniques to immobilize PEG-based antifouling molecules on bioelectronic surfaces 
[41]. Yeh et al. [39] demonstrated the ability of these PEG antifouling molecules in 
SAMs fabricated on gold surfaces in ethanol and via monothiol-functionalized 
hyperbranched polyglycerols. The protein repulsion of these coated surfaces increased 
with increasing density of chains on the surface (Figure 1.1). Other hydrophilic materials 
have been used to prevent surface fouling by creating a surface hydration shell through 
hydrogen-bonding; these include tetraglyme, dextran, mannitol, and polyamines 
functionalized with acetyl chloride [41,42].  
Some common antifouling molecules, including PEG  and polyethylene, have been 
reported to induce the aggregation of biomolecules on the surface of the implantable 
device [43]. More recently zwitterionic polymers have been used as surface modifications 
in implantable devices for their antifouling, antibacterial, and anticoagulant abilities. 
They have also been used for biomedical diagnostics, immunomodulation, and drug 
delivery. Various zwitterions, such as sulfobetaine, carboxybetaine, and 
phosphorylcholine, have been developed to prevent biofouling on implantable devices 
[44]. These zwitterionic polymers are very promising in the development of antifouling 
biomedical devices [45]. Zwitterionic materials have gained popularity in the 




addition to being effective, robust, and stable. There are two main approaches to the 
development of these zwitterionic surfaces. The surface can be modified by a 
homogenous mixture of balanced charged groups from zwitterionic molecules. 
Alternatively, it can be modified with species with mixed charged groups, and the 
charged moieties from different groups together form a zwitterionic surface. Examples of 
these surfaces include mixed charge SAMs [46], hydrogels, and coatings [44,45].  
1.3.2 Self-assembled monolayers with peptides to reduce surface fouling 
A very simple adaptation of a Zwitterionic antifouling peptide is to use amino acids; 
the peptide backbone is naturally zwitterionic, so they can act as antifouling molecules. 
In the development of thiol-gold SAM-based biosensors, cysteine is a prime candidate for 
this application. The sulfur-containing side chain can self-assemble onto a gold surface 
while the charged side is solvent-exposed. It is small and can form a surface with few 
pinholes or impurities; it is also cost-effective and biocompatible. Lin et al. [47] 
demonstrated the antifouling potential of pure cysteine SAMs, and the extend of surface 
fouling was analyzed using quartz crystal microbalance (QCM) and surface plasmon 
resonance (SPR). They were able to reduce surface fouling caused by BSA and 50% 
human blood by 94.81% and 93.79%, respectively. 
More complex antifouling peptides have been investigated as well. Zwitterionic 
peptides have been shown to possess superior antifouling performance when compared to 
amphiphilic peptides of the same length. Ye et al. [48] investigated the antifouling 
abilities of two peptide SAMs, CRERERE and CYSYSYS. Although they both showed 
minimal protein adsorption in single protein samples, the zwitterionic CRERERE peptide 




that mixed-charged peptides attain their surface hydration via ionic solvation, while 








Figure 1.2: Schematic illustration of the attachment of peptide SAMs on the gold surface and 






Mixed-charge peptides have been very effective in resisting surface fouling 
[40,45,46,51]. Glutamic acid (E) and lysine (K) SAMs are highly resistant to the 
nonspecific adsorption of fibrinogen, lysozyme, and serum albumin [46,52]. Aspartic 
acid and arginine have been demonstrated to possess antifouling abilities but to a lesser 
extent; it has been found that the inclusion of arginine may increase nonspecific protein 
adsorption in zwitterionic SAMs [51,53]. The repeating EK motif has been adapted by a 
variety of groups [29,51,54,55]. Several groups have taken this zwitterionic peptide motif 
and adapted it for use in various platforms, including polymers, covalent surface 
coatings, and hydrogels. 
Wang et al. [56] developed an aptasensor for the detection of ATP based on a mixed 
aptamer and peptide SAM. The repeating EK motif and the known zwitterionic 
EKEKEKE-PPPPC [55] peptide sequence were employed in this design. They combined 
an ATP aptamer, which functions as the bio-recognition element to bind ATP, with an 
antifouling peptide diluent to resist non-specific adsorption. Both aptamer and peptide 
were assembled onto a gold nanoparticle-modified gold electrode simultaneously, and the 
electrode was further modified with 6-mercapto-1-hexanol. They analyzed the antifouling 
abilities of the resultant electrode/sensor via EIS. The electrode was incubated in a 
solution containing 1 mg/mL of either BSA, HSA, Lys, or a complex biological matrix: 
human plasma (10%) or human whole blood (5%). In all cases, smaller EIS responses 
were observed when compared to the aptasensor without an antifouling diluent. They 
further demonstrated that the sensor could detect ATP in 1% of whole human blood [56].  
Cui et al. [57] developed a label-free electrochemical DNA-based sensor for the 




zwitterionic peptide, EKEKEKE-PPPPC, was incorporated into the thiol-gold SAM as an 
antifouling diluent. The modified electrode was exposed to increasing concentrations of 
human serum, up to 40%, but the change in EIS signal was not reported. Although this 
design was functional, it was more complex than other types of SAMs. Thus, researchers 
continue to seek simple yet effective ways to incorporate antifouling peptides into 
monolayers to prevent surface fouling. 
In a previous study from our lab, Zaitouna et al. [29] demonstrated the effect 
of incorporating extra amino acids into a thiolated and MB-modified peptide probe in an 
E-PB HIV sensor. The (SG)3 modification primarily improved sensor selectivity while 
the (EK)3 modification primarily enhanced sensor specificity. These sensors were 
functional in 50% synthetic saliva and 50% urine proxy, with minimal change in 
sensitivity and binding kinetics. Furthermore, McQuistan et al. [58] demonstrated the 
potential of DNA-based antifouling diluents in a different E-PB HIV sensor. In this 
design, the peptide recognition element was a 21-residue peptide epitope (DRY-MB) 
from the HIV-1 p24 antigen, and the DNA diluents were thiolated oligo-T. Specifically, 
they compared the antifouling capabilities of T2, T4, and T6 , in addition to addressing 
core issues such as steric hindrance to binding. They observed a strong inverse 
correlation between the diluent chain length and surface coverage, as determined by XPS. 
They further compared the responses of the sensors to random human IgG and the correct 
target, HIV anti-p24 IgG. The addition of the DNA diluents had minimal effects on target 
binding, and they were able to use their sensor in 10% synthetic human saliva. Overall, 
their results have confirmed the use of oligo-T diluents as antifouling agents, and out of 





Figure 1.3: Design and signaling mechanism of the E-PB sensor fabricated with a DNA anti-
fouling diluent (T2, T4, or T6) and the associated signal changes. Reproduced with permission 





1.4.  Electrochemical methods for sensor interrogation 
Techniques used to measure protein adsorption based on changes in physical 
properties include various voltammetric techniques EIS, SPR, and QCM [1,59,60]. SPR 
and QCM measure the changes in resonant frequency of an electronic (SPR) or acoustic 
(QCM) oscillation that are caused by physical changes on the sensor surface. Since these 
techniques measure a property change in both the surface and nearby solution, they 
cannot distinguish between signal changes due to reversible or irreversible protein 
adsorption and signal changes due to the introduction of the protein that is in contact with 
the sensor surface. For SPR the addition of protein to a solution even at concentrations 
below 0.1 mg/mL creates a significant background signal, regardless of whether the 
protein adsorbs to the surface. These techniques require that the surface (optical or 
acoustic) properties be compared before and after protein adsorption to quantify the 
amount adsorbed, resulting in a static measurement of irreversibly adsorbed foulants 
[49,57,61].  
EIS is an electrochemical technique that is also based on the interfacial reaction at the 
electrode surface. When most biological molecules are immobilized on the electrode, 
they act as a layer that prevents redox species from diffusing to the electrode, leading to a 
change in capacitance and impedance. Adsorption and binding of different species from 
the solution further alter the capacitance and impedance of the system. It is a very 
sensitive electrochemical technique, capable of measuring extremely small signals from 
minor changes in the electrode surface [20,30,59].  
The main electrochemical method used in this thesis is alternating-current 




direct current (DC) linear potential ramp. ACV is particularly useful with systems that 
employ a redox label, such as the SAM systems used in the thesis. Thus, the two peptide 
probes were modified with a MB, a well-characterized redox label. It can be readily 
reduced to leuco-methylene blue (LMB) via a two-electron process (Figure 1.4) and can 
be re-oxidized to MB. MB is functional in physiological conditions, with a standard 
reduction potential of about 0.011 V vs. NHE at pH 7 [29,59]. Hence, it is a redox label 
commonly used in biological systems.  Furthermore, for most previously developed E-PB 
sensors and SAM systems, the MB peak in AC voltammograms (ACVs) is well-defined, 
which enables easy analysis of the peak current. The applied frequency and amplitude 
can also be tuned and optimized to achieve the best detection sensitivity. For these noted 
advantages, it was chosen as the main electrochemical interrogation technique for this 












1.5. Thesis objective 
The objective of this thesis was to study the effects of different DNA-based diluents 
on the behavior of E-PB sensors in complex biological matrices. Specifically, the goal 
was to demonstrate the antifouling capabilities of oligothymine (oligo-T) and 
oligoadenine (oligo-A)  when incorporated into self-assembled monolayers, such as those 
commonly used in the fabrication of E-PB sensors. Tetra-thymine (T4) was selected 
since it was used as an antifouling diluent in our previous work [58]. However, it was 
also of interest to assess the efficacy of tetra-adenine (A4) as an antifouling diluent. This 
study facilitates the comparison of the antifouling ability of thymine, a purine, to adenine, 
a pyrimidine.  
The selection of the peptide probe was also an important part of this study since the 
goal was to design an E-PB sensor suitable for the real-time detection of Methicillin-
resistant Staphylococcus aureus (MRSA) in complex biological samples. MRSA 
infection is still a major global healthcare problem, so there is a need to develop 
diagnostics that are faster than conventional culture-based methods and more cost-
effective than PCR-based approaches [62,63]. Although various biorecognition elements 
are available for the detection of MRSA, there are advantages in utilizing antimicrobial 
peptides (AMPs) as probes for the current E-PB sensors [12]. Thus, in this study two 
MRSA-specific AMPs rich in cationic and hydrophobic amino acid residues were 
selected as the peptide probes [63,64]. The compatibility of these two peptides with the 
two DNA diluents, T4 and A4, were systematically characterized, and their responses 
when exposed to two complex matrices, 50% simulated nasal mucus and 100% human 




MRSA, the results could help with the design and fabrication of future E-PB sensors 
suitable for the detection of MRSA, specifically USA300 LAC, in real biological 
samples. The use of oligo-T and oligo-A as antifouling diluents could also benefit other 
surface-based sensors, including SPR and QCM sensors.  
2. Materials and methods 
2.1 Materials and reagents 
6-mercapto-1-hexanol (C6-OH), tris-(2-carboxyethyl) phosphine hydrochloride 
(TCEP), sulfuric acid H2SO4, Tris-EDTA, sodium chloride (NaCl), potassium chloride 
(KCl), magnesium chloride (MgCl2), calcium chloride (CaCl2), acetonitrile (ACN), 
human serum (human male AB plasma, USA origin, sterile-filtered Lot # SLCJ3816), 
were all purchased from Sigma-Aldrich (St. Louis, MO) and used as received. All other 
chemicals were of analytical grade. The simulated nasal mucus, BZ253, was purchased 
from BioChemazone (Ontario, Canada). All solutions were made with deionized (DI) 
water purified through a Millipore Synergy system (18.2 MΩ∙cm, Millipore, Billerica, 
MA). The buffer used for probe and C6-OH immobilization was a pH 7.4 2X Phys2 
buffer with 40 mM Tris, 280 mM NaCl, 10 mM KCl, 2 mM MgCl2, and 2 mM CaCl2. 
The sensor interrogation buffer was a pH 7.4 Phys2 buffer with 20 mM Tris, 140 mM 
NaCl, 5 mM KCl, 1 mM MgCl2, and 1 mM CaCl2. 
Peptide probes (P1 and P2) with the following sequences were purchased from Xaia 
Custom Peptides (Göteborg, Sweden) and used as received.  
Thiolated and MB-modified Peptide Probes:  




P2: (n) HS-(CH2)6- IKWKKLLRAAKRIL-K-MB (c) 
The probe was modified at the n-terminus with a 6-carbon alkanethiol (C6), and at the 
c-terminus with a methylene blue (MB) redox label. The MB label was conjugated to the 
added lysine (K) residue at the c-terminus. Two types of thiolated DNA diluents with the 
following sequences were purchased from Sangon Biotech Co., Ltd. (Shanghai, China).  
Thiolated DNA Diluents 
T4: 5’ HS-(CH2)6-TTTT 3’ 
A4: 5’ HS-(CH2)6-AAAA 3’ 
The lyophilized peptides were reconstituted in 20% ACN (80% deionized (DI) water) 
to produce 0.2 mM stock solutions, which were further diluted prior to sensor fabrication. 
The lyophilized DNA diluents were reconstituted using 1X Tris-EDTA to a create 0.2 
mM stock solutions. TCEP was added to the solutions to reduce the disulfide bonds and 
further diluted to concentrations required for sensor fabrication. 
2.2 Instrumentation 
A 1040B CH Instruments Workstation (Austin, TX) was used for all electrochemical 
measurements. Gold working electrodes of 2 mm diameter, Pt auxiliary electrode, and 
Ag/AgCl (1M KCl) reference electrode made up the electrochemical cell. All electrodes 
in the electrochemical cell were also purchased from CH Instruments. Alternating current 
voltammetry (ACV) was the main technique for sensor characterization. AC 
voltammograms were recorded from -0.05 V to -0.45 V at 10 Hz with an AC amplitude 
of 25 mV. CV was used specifically to determine the probe coverage. All electrochemical 




2.3 Preparation of gold working electrodes 
Prior to sensor fabrication, the gold electrodes were mechanically polished for 15 
minutes with a 6 µm diamond suspension (Buehler, Lake Bluff, IL) and sonicated in an 
ultrasonic bath for 5 minutes in DI water. Next, they were polished for 10 minutes with a 
3 µm diamond suspension and sonicated for 5 minutes in DI water. They were further 
polished for 5 minutes with a 1 µm diamond suspension and sonicated for 5 minutes in 
DI water. The electrodes were then electrochemically cleaned by cycling from -0.2 to 1.3 
V at 4 V/s in 0.50 M H2SO4 until a minimal change in the current was observed. The real 
surface area of each electrode was determined using CV. Specifically, the charge under 
the cathodic peak at ~0.85 V in the CV scan recorded at 100 mV/s in 0.05 M H2SO4was 
used to calculate the real surface area of the electrode. Electrodes with a ρ factor (actual 
area/geometric area) between 1.0 and 1.3 were deemed acceptable and were used to 
fabricate the sensors. The electrodes were rinsed with DI water and dried with nitrogen 
gas before the SAM formation. 
 2.4 Sensor fabrication 
Fabrication of the six sensors used in this study involved two steps: 1) immobilization 
of the peptide probe with or without the DNA diluent, 2) immobilization of C6-OH. In 
brief, to prepare the P1 and P2 sensors (i.e., sensors without an antifouling diluent), 15 
μL of 1 µM P1 or P2 was drop cast onto the electrodes for 1 hour, followed by 
incubation in a 2 mM C6-OH solution for 17 hours. A similar two-step approach was 
used to fabricate sensors with a DNA antifouling diluent. To fabricate the P1/T4 sensor, 
1 µM P1 and 1 µM T4 were used in the first step, whereas for the P2/T4 sensor, 1 µM P2 




were co-immobilized in the first step. For the P2/A4 sensor, 1 µM P2 and 1 µM A4 were  
used, and unlike the procedure used in the fabrication of the P1/T4, P2/T4, and P1/A4 
sensors, the immobilization time was 6 hours instead of 1 hour. For all four DNA diluent-
containing sensors, the second step involved immobilization of C6-OH for 17 hours.  
2.5 Probe coverage determination and sensor characterization 
CV was used to determine the number of peptide probes (Γ) using Equation 1, where 
Q is the charge associated with the reduction of MB at slow scan rates (10, 50, and 100 
mV s-1), F is the Faraday’s constant, n is the number of electrons transferred in the 
electrochemical reaction (n = 2 for MB). 
𝛤 = 𝑄/𝑛𝐹 
(1) 
The antifouling capability of the sensors was characterized through electrochemical 
interrogation by comparing the MB peak current before and after exposure to a complex 
matrix. The stability of the sensors in a pure buffer (Phys2) was assessed prior to 
analyzing their responses in a complex matrix. The MB current was monitored using 
ACV until the change in current was less than a 0.5%. All six sensors, P1, P2, P1/T4, 
P2/T4, P1/A4, and P2/A4, were interrogated in both 100% human serum and 50% 
artificial nasal mucus (50% 2X Phys2). The 2X buffer was used to dilute the artificial 
sample to ensure that the ionic strength of the sample was suitable for electrochemical 
analysis. 
The % signal suppression (%SS) was calculated using Equation 2. 





where I0 is the baseline-subtracted MB current prior to the addition of the complex 
matrix, and I is the baseline subtracted MB current in the presence of the complex matrix. 
Unless stated otherwise, all data presented here are averages from three independent 
experiments (n = 3).  
Sensor regeneration was performed by incubating each sensor first in 1% Triton X for 
4 minutes, next in base salt (25 mM NaOH 100 mM NaCl) for 4 minutes and followed by 
a DI water rinse. At the end of each experiment, the monolayer was removed via both 
oxidative and reductive desorption. In the first step, the electrodes were scanned from -
0.2 to -1.4 V at a scan rate of 20 mV s−1 in 0.5 M NaOH to remove bulk of the 
monolayer. Next, they were subjected to electrochemical cleaning in 0.5 M H2SO4 to not 





3. Results and discussion 
3.1 Selection of cationic antimicrobial peptide probes 
Naturally occurring AMPs are widespread host defense molecules that have retained 
their effectiveness throughout the years [65]. This is due to multiple mechanisms of 
action such as membrane disruption, and thus it is rare for bacteria to develop a resistance 
to these AMPs. They show great potential as therapeutics to combat new antibiotic-
resistant bacterial strains, and hopefully quell the evolution of more dangerous bacteria 
[65]. A wide range of AMPs have since been developed, including those specific for 
MRSA USA300, a family of genetically related bacterial strains that are a major issue 
globally. It is worth noting that deaths from MRSA are rapidly increasing and have been 
since its emergence in the 1960s [62]. The availability of high efficacy AMPs could 
expand the treatment options available for MRSA infections. 
Although there are naturally occurring AMPs, many researchers have employed 
various approaches to design new AMPs for therapeutic applications. For example, 
Menousek et al. synthesized multiple computationally designed AMPs and analyzed their 
ability to target and kill MRSA, specifically USA300 LAC [64]. These AMPs were 
designed to possess a net positive charge since cationic peptides are ideal for targeting 
gram-positive bacteria. They also do not contain cysteine residues for ease of synthesis. 
Some of the AMPs were redesigned from natural peptide templates but with added 
positively charged residues to increase their efficacy [66]. All of these peptides were part 
of the Antimicrobial Peptide Database (APD), which housed a collection of AMPs from 
bacteria, fungi, plants, and animals that display narrow or broad-spectrum activity against 




AMPs as of January 2012, and while this database is no longer available or being 
updated, several more specialized databases are still available.  
Several MRSA-specific AMPs were identified by Mishra et al. and Menousek et al.  
via database screening [63,64]. And out of the sequences identified, two peptides, 
DASamP1 (P1) and DASamP2 (P2),  were selected as the peptide probes for this study 
because of their similarities in charge and sequence length. P1 is a peptide mutant of 
temporin-PTa with S4K, P10R and L13F mutations, while P2 is a peptide mutant of 
polybia-MPI with D2K, D8R and Q12R mutations. P1, with the sequence 
FFGKVLKLIRKIF, has a +5 net charge at pH 7, whereas P2, with the sequence 
IKWKKLLRAAKRIL, has a +7 net charge at the same pH. Like most AMPs, they are 
composed entirely of hydrophobic and basic amino acid residues. They were both active 
against USA300 LAC, with minimum inhibitory concentrations (MICs) of 3.2 and 6.1, 
respectively. P1 showed activity exclusively against Gram-positive USA300 LAC; 
however, P2 responded to another Gram-positive bacteria, b. subtilis, as well as two 
Gram-negative bacteria, P. aeruginosa and  E. coli. It was considered a broad-spectrum 
AMP. Both peptides only displayed notable hemolysis at concentrations higher than that 
required to kill USA300 LAC, verifying their ability to selectively target bacterial 
membranes without lysing mammalian cells. 
It is worth noting that P1 was shown to prophylactically reduce USA300 LAC 
colonization and biofilm formation on artificial surfaces in vivo [66]. It was also used to 
prophylactically reduce bacterial colonies in biofilms, specifically those associated with 
catheters and other medical implants. Bacteria in a biofilm are physically protected from 




most immunotherapy ineffective. Hence, the only option for dealing with biofilms 
developing around an artificial device is an inconvenient cycle of removal and 
replacement. As P1 was demonstrated to quell biofilm formation in vivo, it is a potential 
surface treatment for permanent medical implants such as hips, knees, or heart valves. 
Overall, P1 has shown to be a promising therapeutic agent for MRSA, specifically 
USA300 LAC. 
Although both P1 and P2 were designed for therapeutic applications, they can 
potentially be used as biorecognition probes in the design of sensors. The use of AMPs as 
biorecognitions have been reported; however, no MRSA sensors that employed AMPs 
have been reported to date. Thus, in this study we selected these two AMPs, P1 and P2, 
as the peptide probes and further modified them to ensure compatibility with the E-PB 
sensing platform Specifically, they were modified at the n-terminus with a C6-thiol and at 
the c-terminus a MB label (Figure 3.1). The goal of this study was to assess the behavior 
of these two model peptide probes, both in the absence and presence of DNA diluents, T4 
and A4 (Figure 3.1), when exposed to complex biological samples. While this study’s 
immediate focus was not on the actual detection of USA300 LAC, the results are 
significant and will greatly benefit the E-PB sensing platform. This study has laid the 
foundation for future advances in the design and fabrication of E-PB MRSA sensors that 















3.2 Incorporating DNA diluents into cationic peptide-containing SAMs 
Prior to the incorporation of DNA antifouling diluents, both  P1  and P2 probes were 
independently tested to ensure that stable monolayers with reproducible coverage could 
be achieved. This step was needed since hydrophobic and cationic peptides have not been 
used extensively in the design and fabrication of E-PB sensors. First, the effects of the 
ionic strength of the probe immobilization solution were assessed. It was determined that 
drop casting the peptides probe in a higher ionic strength solution produced a more stable 
monolayer. The use of the Phys2 buffer in the probe immobilization step did not produce 
a stable monolayer even after 1 hour of equilibration, whereas the use of the 2X Phys2 
buffer in the same process resulted in a monolayer that was stable after 10  min of 
equilibration. 2X Phys2 was thus used as the probe immobilization buffer for the rest of 
the study for the P1 and P2 systems, as well as the four systems that incorporated DNA 
diluents, P1/T4, P1/A4, P2/T4, and P2/A4. 
Unlike the P1 and P2 systems, which are two-component SAMs, fabrication of three-
component SAMs is more complex, and the probe immobilization process could have a 
major positive or negative effect on the resultant SAM. Thus, the probe immobilization 
process must be strategically designed to ensure adequate incorporation of both peptide 
probe and DNA diluent. The resultant monolayer should also be stable within the 
experiment timeframe (e.g., 8 hours). Various SAM formation processes were evaluated 
in this study, and out the methods tested,  direct co-immobilization of peptide and DNA 
probes in a single step was found to be the best approach. This approach is different the 
one used in our previous work, wherein the DNA diluent, T4, was introduced into the 




Using the co-immobilization method, the resultant SAMs were relatively stable and 
were suitable for the intended antifouling study. Both ACVs and CVs of the four systems, 
P1/T4, P1/A4, P2/T4, and P2/A4, are shown in Figure 3.2 and Figure 3.3. The 
voltammograms of the two DNA-free systems, P1 and P2, are also included for 
comparison. As can be seen, there are a few similarities between the two systems. For the 
two systems without a DNA diluent, the MB peak potential in ACV was ~-0.25 V, which 
is consistent with the MB reduction potential in a C6-based SAM. However, the MB peak 
potential shifted to a slightly more negative value for the monolayers with both peptide 
and DNA probes. For the P1/T4 and P1/A4 systems, the MB peak potential was at ~-0.29 
V, whereas for the P2/T4 and P2/A4 systems, the peak potential was at ~-0.27 V. These 
trends were also observed in the CVs but to a significantly lesser extent (Figures 3.2 and 
3.3).  
The incorporation of T4 altered the peak shape for both peptide systems, as indicated 
by the slight peak broadening. This is likely due to the lack of surface homogeneity and 
the presence of peptide and/or DNA clusters in the monolayer, which is expected for a 
complex three-component SAM. However, this effect was more prominent for the A4-
containing systems, specifically the P1/A4 system. Significant peak broadening was 
evident with this system, further indicating the lack of monolayer uniformity. Adenine, 
unlike thymine, is a larger base with two rings, and oligo-A and polyadenine are known 
to pi-stack under physiological conditions [68]. This could influence the packing and 
structure of the monolayer. Despite the minor differences in the shape and width of the 
MB peak, these results have demonstrated the successful fabrication of three-component 




for all six systems were relatively large, the actual probe coverages were much lower 
than previously developed sensors, such as the electrochemical DNA and electrochemical 
aptamer-based sensors. Because of the lower probe coverages, ACV, instead of CV, was 






Figure 3.2: Representative ACVs and CVs for the three systems, P1, P1/T4, and P1/A4. All 






Figure 3.3: Representative ACVs and CVs for the three systems, P2, P2/T4, and P2/A4. 





3.3 Antifouling capability of DNA diluents in peptide-containing SAMs 
The ability of a monolayer to resist surface fouling is often dependent on the amount 
of antifouling diluent incorporated during the monolayer formation process. Thus, it is of 
utmost importance to optimize the amount of T4 or A4 in the two peptide systems. 
Various concentrations of the DNA diluents were used in this study, and the optimal 
results are presented in Sections 3.4 and 3.5. Once optimized, all six systems were tested 
in two complex biological fluids, 50% simulated nasal mucus and 100% human serum. 
The two samples were chosen because they are well-suited for the analysis of MRSA. 
Intact MRSA bacterial cells could be found in nasal mucus and sputum, as well as blood 
serum. If the E-PB sensors, as designed, are functional in these two samples, they can 
potentially be used as real-time biosensors for detection of MRSA. It is worth noting that 
the buffer (Phys2) chosen for the fabrication and initial interrogation of the sensors was 
designed to mimic human serum in ionic strength and ion composition. Electrochemical 
analysis is highly dependent on the ionic strength of the solution, and thus when 
transferring the electrodes/sensors from one solution to another, it is important to 
minimize the change in ionic strength to limit the change in the background signal. 
However, since the ionic strength of the simulated nasal mucus is unknown but presumed 
to be relatively low, it was necessary to dilute it with a 2x Phys2 buffer to ensure that the 
ionic strength of the final solution was appropriate for electrochemical analysis.  
The schematic representations for the six systems are shown in Figures 3.4 and 3.5. In 
brief, prior to exposure to a complex matrix with proteins and other contaminants, the 
electron transfer between the MB label and the underlying electrode is efficient. 




contaminants onto the monolayer could occur, dampening the electron transfer and 
resulting in a large reduction in the MB current. Although it might not be possible to 
eliminate surface fouling, the extent of surface fouling is likely to be more severe for 
















3.4 Antifouling behavior of DNA diluents with P1 peptide in complex 
matrices 
The P1 system was first analyzed since it was the control system without the 
incorporation of a DNA diluent. As can be seen in Figures 3.6A and 3.6D, the monolayer 
was incapable of resisting surface fouling. A relatively large signal suppression (SS) was 
observed upon exposure to the complex matrices, namely 53±3% in the simulated nasal 
mucus and 69±10% in human serum. Next, we optimized the responses of the P1/T4 
system in the presence of the complex samples. The key adjustable parameter was the 
amount of T4 incorporated into the monolayer, which has been shown to be dependent on 
the concentration of the DNA diluent used in the monolayer formation process. Although 
the exact amount incorporated might not change linearly with the immobilization 
concentration, it was still the most important part of the optimization process.  
For the P1/T4 system, the concentration of P1 was kept at 1 µM, but a range of DNA 
concentrations was used in the co-immobilization step. When 0.1 µM T4 was used, the 
antifouling effects were minimal, and the %SS was very large in both complex samples. 
It is possible that the amount of adsorbed T4 was inadequate to produce any antifouling 
effect. However, when 1 µM T4 was used, the %SS was significantly lower, indicating 
good antifouling behavior. Higher concentrations of T4, including 10 and 100 µM, were 
tested, but the effects were not comparable to those obtained with 1 µM T4. For example, 
the monolayer fabricated with 1 µM T4 showed 3±3 %SS in 50% simulated nasal mucus, 
whereas the one with 10 µM T4 showed ~16% SS. The same trend was observed when 




T4 showed 27±9 %SS, and the monolayer with 10 µM T4 produced ~48 %SS. Thus, it 
was determined that 1 µM T4 was the optimal concentration.  
Although the P1/T4 system displayed good antifouling behavior, it was important to 
test other DNA diluents and compare their performances. Oligo-T such as T4 was used in 
our previous study [58], but oligo-A has not been tested in this manner. Adenine has been 
employed to create antifouling surfaces, but it was through preferential adsorption of the 
nucleotides on gold surfaces, with the charged phosphate backbone exposed to the 
solvent [69]. Huang et al. adapted this method to the fabrication of their EIS sensor [69]. 
Thus, the use of a thiolated oligo-A diluent, such as A4, for surface passivation has not 
been reported to date. 
The effects of introducing different concentrations of A4 into the P1 system was 
investigated. When 1 µM A4 was used in the co-immobilization step, the %SS in nasal 
mucus was ~1%, but when 10 µM A4 was used, the %SS was only 0.6±0.4%. Similarly, 
when 1 µM A4 was used in the fabrication of the monolayer, the %SS was ~18 % in 
human serum, whereas the monolayer fabricated with 10 µM A4 showed 11±5 %SS. 
These results show that 10 µM A4 was optimal for fabricating monolayers with good 
antifouling behavior. Representative ACVs of the optimized P1/T4 and P1/A4 systems 
when exposed to the two biological samples are shown in Figure 3.6, and the average 
%SS are shown in Table 1. It is worth mentioning that the MB peak potential was shifted 
slightly to a more negative potential when the systems were exposed to undiluted human 
serum. This is expected since the pH of the human serum used in this study was 7.9, 
which is slightly more basic than the Phys2 buffer at pH 7.4. The redox potential of MB 




observed in other sensors developed by our group. However, the peak shape of MB for 
both systems was not noticeably altered after the introduction of human serum. As for the 
systems tested in 50% simulated nasal mucus, the MB peak potential shifted slightly to a 
more positive value, which is expected since the pH of this solution was 6.8, more acidic 
than the pH of the Phys2 buffer.  
Overall, our results show that the incorporation of either T4 or A4 can improve the 
monolayer’s ability to resist surface fouling. The extent of surface fouling was more 
severe in undiluted human serum when compared to the 50% simulated nasal mucus. It is 
expected since the human serum was not diluted, and serum, in general, is a more 
complex biological matrix than nasal mucus. These results also allude to the fact that the 
concentration of DNA diluents used in the monolayer fabrication process may not reflect 
the amount incorporated into the monolayer. Formation of a three-component SAM is a 
complex process, and each system must be individually optimized. The exact amount of 
DNA diluents incorporated into the optimized monolayers will be determined by XPS, 







Figure 3.6: Representative ACVs for the P1, P1/T4, and P1/A4 systems before and after 
exposure to either 50% simulated nasal mucus or 100% human serum. All ACVs were obtained at 





3.5 Antifouling behavior of DNA diluents with P2 peptide in complex matrices 
The effects of the DNA diluent concentration used in the monolayer formation 
process were also investigated for the P2 system. The P2 system (i.e., the system without 
a DNA diluent) showed ~64±1 %SS and 70±10% SS in the nasal mucus and human 
serum samples, respectively. Despite the differences in the peptide sequence length and 
charge, these values are comparable to those for the P1 system. Both systems are 
incapable of resisting surface fouling without an antifouling diluent. Like the P1 system, 
the concentration of P2 was also kept at 1 µM while a range of DNA concentrations were 
tested. Our results show that when 0.1 µM T4 or A4 was used in the fabrication step, the 
antifouling effects were not apparent. The monolayer did not have adequate amount of 
DNA diluents to elicit an effect. When 1 µM T4 was used in co-immobilization step, the 
%SS was ~12% in the nasal mucus sample, but the %SS reduced to 8±1 % when 10 µM 
T4 was used. This difference was even more drastic when the system was exposed to 
undiluted human serum. The %SS was ~65% for the monolayer fabricated with 1 µM T4, 
but the %SS was -2±4% when the concentration of T4 was 10 µM. The use of a higher 
concentration such as 20 µM did not result in a monolayer with better antifouling 
properties. Thus, it was determined that 10 µM T4 was the optimal concentration for the 
P2/T4 system.  
A similar monolayer immobilization and optimization process was used for the 
P2/A4 system. The concentration of P2 was kept at 1 µM, but different concentrations of 
A4 were tested. For example, when the monolayer was fabricated with 1 µM A4, the 
%SS was ~14±7% in undiluted human serum, but when the concentration was increased 




such as 20 µM, did not result in a monolayer with lower %SS. The optimal A4 
concentration was determined to be 1 µM for the P2/A4 system. Representative ACVs of 
the optimized P2/T4 and P2/A4 systems when exposed to the two biological samples are 
shown in Figure 3.7, and the average %SS are shown in Table 1. The slight shifts in the 
MB peak potential were evident when the P2/T4 and P2/A4 systems were exposed to the 
two samples; however, the shifts were minimal when compared to those observed with 
the P1/T4 and P1/A4 systems. These changes could be due to the differences in the 
nature of the two peptides. P2 is a 14 amino acid peptide and with a +7 charge, and P1 is 
a 13 amino acid peptide with a +5 charge. The structure and orientation of the two 
peptides, once immobilized on the electrode surface, could be rather different. The exact 
amount of DNA diluents incorporated in the monolayer could also be different for the 
two peptide systems. Thus, XPS will be employed to quantify the amount of DNA 
diluents for all these systems. In summary, we have confirmed the efficacy of both T4 
and A4 as antifouling diluents for systems containing cationic AMPs. The results are 
promising and will be useful for future designs of E-PB MRSA sensors that can be 







Figure 3.7: Representative ACVs for the P2, P2/T4, and P2/A4 systems before and after 
exposure to either 50% simulated nasal mucus or 100% human serum. All ACVs were obtained at 






Table 1: The %SS obtained for the six systems in the presence of the two different 
complex matrices. The values are averages from three different electrodes fabricated 
simultaneously, with the error reported as one standard deviation. 
  
Peptide Biological matrix Peptide control Peptide + A4 Peptide + T4 
P1 Serum 69±10% 11±5% 27±9% 
Nasal Mucus 53±3% 0.6±0.4% 3±3% 
P2  Serum 70±10% 14±7% -2±4% 




3.6 SAM fabrication reproducibility  
While we have demonstrated the efficacy of both T4 and A4 as antifouling diluents, 
we cannot claim that the systems were highly reproducible, as indicated by the large 
error bars in the reported values. However, the responses of all six systems in 50% nasal 
mucus were more reproducible when compared to those in the undiluted human serum. 
The protein content of nasal mucus is relatively low even though the exact composition 
of the samples used in this study is not known (i.e., proprietary formulation). Human 
serum contains lots of proteins and other potentially interfering species, and thus very 
few studies in the literature employed undiluted human serum as the main sample. 
Although we tested many different probe/diluent immobilization approaches, none of 
them was better than the one used to obtain the reported results. Owing to the 
complexity of a three-component monolayer, additional optimization processes will be 
needed to improve sample-to-sample reproducibility, and this will be part of the future 
work. 
4. Conclusion  
4.1 Summary of Work 
We have demonstrated the use of DNA diluents to reduce surface fouling in cationic 
peptide-containing SAMs. Previous work from our group showed that oligo-T was an 
effective antifouling diluent and was thus used in the fabrication of an E-PB HIV sensor 
[58]. Our current study is an extension of this work but with the focus on addressing 
several previously unexplored aspects. First, we assessed the efficacy of oligo-A, such as 
A4, as an antifouling diluent. Second, instead of utilizing peptides directly from an 




hydrophobic nature, they are more challenging to work with; formation of a stable and 
high probe coverage monolayer could be an issue. However, our work has demonstrated 
that both P1 and P2 , despite being cationic and partially hydrophobic in nature, can form 
reasonably stable SAMs and with coverages suitable for the E-PB sensing platform. 
Furthermore, both P1 and P2 systems, when co-immobilized with T4 or A4, can resist 
surface fouling, as indicated by the low %SS obtained in two complex biological 
samples, 50% simulated nasal mucus and undiluted human serum. In summary, this work 
has addressed an important issue in the design and fabrication of E-PB sensors, which is 
surface fouling. Specifically, it highlights the use of short chain DNA sequences as 
antifouling diluents, a surface passivation approach that is compatible with a wide range 
of SAM-based sensing platforms.  
4.2 Future Studies 
While we have observed the positive effects of incorporating DNA diluents into the 
monolayers, we have not quantified the exact amount of DNA diluents in the sample. We 
are currently preparing samples for the XPS analysis. Similar to our previous study, the 
amount of phosphorous in the sample will enable indirect quantification of the DNA 
diluent in each system [58]. Although it will not provide information on the homogeneity 
of the three-component SAM, the results will still be invaluable as it is necessary to 
correlate the antifouling behavior to the amount of DNA diluents incorporated into the 
monolayer. In addition to the XPS analysis, part of the future work is to test the four 
systems, P1/T4, P1/A4, P2/T4, and P2/A4, against USA300 LAC as well other bacteria. 




Although these systems have demonstrated to function well, parameters such as peptide 
probe coverage might have to be adjusted for real-time detection of USA300 LAC. 
It is worth noting that while only two AMPs, P1 and P2, were used in this study, 
there are other MRSA-specific AMPs available in the literature. Many of them are 
cationic and partially hydrophobic in nature, so the same or similar monolayer fabrication 
could be employed. Creating a paper-based sensor array with multiple pixels, each 
modified with a different MRSA-specific AMP, is also part of the future work. T4 and 
A4 have shown to be effective antifouling diluents, but oligo-C such as C4 can 
potentially be used for the same purpose. While G4 is another candidate, it might be 
more challenging to immobilize it on a surface since oligo-G sequences readily form G-
quadruplexes and related structures in solution and on surfaces. Thus, only C4 will be 
employed in the future study. 
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